SPONSOR
Chengdu Zenitar Biomedical Technology Co., Ltd
Total Trials
2
Recruiting
2
Phases
Phase 2
Chengdu Zenitar Biomedical Technology Co., Ltd is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Atopic Dermatitis, MF.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Chengdu Zenitar Biomedical Technology Co., Ltd
How many clinical trials has Chengdu Zenitar Biomedical Technology Co., Ltd sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Chengdu Zenitar Biomedical Technology Co., Ltd, of which 2 are actively recruiting participants. These trials cover conditions including Atopic Dermatitis, MF. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Chengdu Zenitar Biomedical Technology Co., Ltd research focus on?
Chengdu Zenitar Biomedical Technology Co., Ltd clinical trials span Atopic Dermatitis, MF. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Chengdu Zenitar Biomedical Technology Co., Ltd clinical trial?
To participate in a Chengdu Zenitar Biomedical Technology Co., Ltd trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Chengdu Zenitar Biomedical Technology Co., Ltd trials with current recruitment status updated daily.
Clinical Trials by Chengdu Zenitar Biomedical Technology Co., Ltd
NCT07193589 Phase 2
Recruiting
A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis
Atopic Dermatitis
NCT07443306 Phase 2
Recruiting
A Clinical Trial of Flonoltinib Maleate Tablets in the Treatment of JAK Inhibitor Refractory/Relapsed/Intolerant Patients With Medium to High Risk Myelofibrosis
MF
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology